Sanofi
- Country
- 🇫🇷France
- Ownership
- Public
- Employees
- 87.9K
- Market Cap
- $141.3B
- Website
- http://www.sanofi.com
- Introduction
Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the following business segments: Pharmaceuticals, Consumer Healthcare, and Vaccines. The Pharmaceuticals segment comprises the commercial operations of the following global franchises: specialty care, diabetes and cardiovascular, established prescription products and generics, and research, development, and production activities. The Consumer Healthcare segment includes the commercial operations for its Consumer Healthcare products. The Vaccines segment consists commercial operations of Sanofi Pasteur. The company was founded in 1973 and is headquartered in Paris, France.
A Safety and Efficacy Study of Two Japanese Encephalitis Vaccines ChimeriVax™-JE and JE-VAX
- Conditions
- Japanese Encephalitis
- Interventions
- Biological: ChimeriVax™-JEBiological: JE-VAX®
- First Posted Date
- 2006-04-13
- Last Posted Date
- 2012-12-06
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 820
- Registration Number
- NCT00314145
Efficacy and Safety of SR46349B in Patients With Sleep Disorders in Fibromyalgia
- Conditions
- FibromyalgiaSleepChronic Pain
- Interventions
- Drug: eplivanserin (SR46349)Drug: placebo
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2010-11-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 205
- Registration Number
- NCT00313885
- Locations
- 🇺🇸
Wichita Clinic PA, Wichita, Kansas, United States
🇺🇸Jacksonville Center for Clinical Research, Jacksonville, Florida, United States
🇺🇸Renstar Medical Research, Ocala, Florida, United States
SAM - Skip a Meal - Insulin Glargine, Diabetes Mellitus Type 1
- Conditions
- Diabetes Mellitus, Type 1
- First Posted Date
- 2006-04-12
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 91
- Registration Number
- NCT00313937
- Locations
- 🇩🇪
Sanofi-Aventis, Berlin, Germany
Docetaxel in Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2006-04-07
- Last Posted Date
- 2013-12-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 3299
- Registration Number
- NCT00312208
- Locations
- 🇻🇪
Sanofi-Aventis, Caracas, Venezuela
🇳🇿Sanofi-aventis, Auckland, New Zealand
Insulin Glargine in Type 2 Diabetes Mellitus
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2009-09-15
- Lead Sponsor
- Sanofi
- Registration Number
- NCT00311818
Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs
- Conditions
- Deep Venous Thrombosis
- Interventions
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2016-03-21
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 757
- Registration Number
- NCT00311090
- Locations
- 🇷🇺
Sanofi-aventis, Moscow, Russian Federation
🇲🇽sanofi-aventis Mexico, Mexico, Mexico
🇹🇷sanofi-aventis Turkey, Istanbul, Turkey
Insulin Glulisine in Healthy Lean and Obese Subjects
- Conditions
- Diabetes Mellitus
- First Posted Date
- 2006-04-05
- Last Posted Date
- 2009-12-07
- Lead Sponsor
- Sanofi
- Registration Number
- NCT00311077
Insulin Glulisine in Type 2 Diabetes Mellitus
- Conditions
- Type 2 Diabetes Mellitus
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2011-01-11
- Lead Sponsor
- Sanofi
- Registration Number
- NCT00310297
Efficacy and Safety of Eplivanserin 5mg/Day on Sleep Maintenance Insomnia
- Conditions
- Sleep Initiation and Maintenance DisordersInsomnia
- Interventions
- Drug: placeboDrug: eplivanserin (SR46349)
- First Posted Date
- 2006-03-29
- Last Posted Date
- 2010-11-30
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 608
- Registration Number
- NCT00308503
- Locations
- 🇨🇦
Sanofi-Aventis, Laval, Canada
Evaluation of the Efficacy of Xaliproden (SR57746A) in Preventing the Neurotoxicity of Oxaliplatin / 5FU/LV Chemotherapy.
- Conditions
- MetastasesColorectal NeoplasmsColorectal Carcinoma
- Interventions
- First Posted Date
- 2006-03-21
- Last Posted Date
- 2016-05-04
- Lead Sponsor
- Sanofi
- Target Recruit Count
- 879
- Registration Number
- NCT00305188
- Locations
- 🇬🇧
Sanofi-Aventis Administrative Office, Guildford Surrey, United Kingdom